Aardvark Therapeutics, Inc.
AARDNasdaqCIK 1774857HealthcareFiscal year ends Dec 31
Reports and events: 35 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2312:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-429509 |
| 2026-10-2220:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-428943 |
| 2026-10-0820:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-417935 |
| 2026-08-1720:10 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-354053 |
| 2026-08-1121:09 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-344987 |
| 2026-08-1121:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344978 |
| 2026-07-1020:05 ET | DEF 14A | Proxy statementPeriod 2026-08-14 | 0001193125-26-300874 |
| 2026-06-1220:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-269377 |
| 2026-05-1420:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-224069 |
| 2026-05-0713:32 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-210675 |
| 2026-05-0713:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210664 |
| 2026-03-2422:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-120164 |
| 2026-03-2320:19 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-119770 |
| 2026-03-2320:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-119727 |
| 2026-02-2721:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-082787 |
| 2026-02-1213:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-047757 |
| 2026-02-1013:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-043764 |
| 2026-01-1213:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009862 |
| 2025-12-1021:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-314364 |
| 2025-11-1321:29 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-280260 |
| 2025-11-1321:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-280235 |
| 2025-11-0623:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-267402 |
| 2025-11-0421:19 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-264748 |
| 2025-10-0921:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-234722 |
| 2025-09-0300:56 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-112645 |
| 2025-08-1320:47 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108116 |
| 2025-08-1320:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108082 |
| 2025-08-1220:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-107320 |
| 2025-05-1420:50 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071560 |
| 2025-05-1420:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-071477 |
| 2025-03-3120:45 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-047835 |
| 2025-03-3120:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-047769 |
| 2025-02-1421:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-027245 |
| 2025-02-0621:02 ET | S-1/A | Registration statement, amended | 0001193125-25-021764 |
| 2025-01-2321:57 ET | S-1 | Registration statement | 0001193125-25-011499 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.